PTCy-based haploidentical vs matched related or unrelated donor reduced-intensity conditioning transplant for DLBCLPeter Dreger, Mehdi Hamadani, Anna Sureda et al.|Blood Advances|2019Cited by 115
Characteristics and Outcome of Patients After Allogeneic Hematopoietic Stem Cell Transplantation Treated With Extracorporeal Membrane Oxygenation for Acute Respiratory Distress Syndrome*Philipp Wohlfarth, Peter Schellongowski, Catherina Lueck et al.|Critical Care Medicine|2017Cited by 83
Post-transplant cyclophosphamide versus anti-thymocyte globulin for graft-versus-host disease prevention in haploidentical transplantation for adult acute lymphoblastic leukemiaArnon Nagler, Mohamad Mohty, Abraham S. Kanate et al.|Haematologica|2020Cited by 56
Long-term outcome after allogeneic hematopoietic stem cell transplantation for Shwachman–Diamond syndrome: a retrospective analysis and a review of the literature by the Severe Aplastic Anemia Working Party of the European Society for Blood and Marrow Transplantation (SAAWP-EBMT)Simone Cesaro, Carlo Dufour, Marta Pillon et al.|Bone Marrow Transplantation|2020Cited by 47
Post-transplant cyclophosphamide-based haplo-identical transplantation as alternative to matched sibling or unrelated donor transplantation for non-Hodgkin lymphoma: a registry study by the European society for blood and marrow transplantationSascha Dietrich, H Finel, Carmen Martı́nez et al.|Leukemia|2016Cited by 44